Skip to content

Biomarkers in Dyspnea

Biomarkers in Dyspnea

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03056547
Acronym
BIODYSPNEE
Enrollment
34
Registered
2017-02-17
Start date
2017-11-23
Completion date
2019-01-08
Last updated
2019-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Brief summary

To explore biological mechanisms in human model of induced dyspnea, in order to remove the source of dyspnoea, to modify cerebral impact and to allow the development of targeted therapies.

Detailed description

The aim of the study will be to identify a specific biology and immunology associated with dyspnoea. It will open therapeutic possibilities through a better understanding of the mechanisms of dyspnea. Healthy volunteers will underwent two types of dyspnea. The subjects will be first familiar with both types of dyspnea and dyspnea measurement scales. Different components of dyspnea will be measured. Blood tests will be performed at different times (before dyspnea, during dyspnea, 60 and 90 min after dyspnea)

Interventions

OTHERInduced dyspnea

Biological samples will be assessed during and after breathing discomfort induced by laboratory models of dyspnea (work/effort, air hunger).

Sponsors

Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* healthy volunteers

Exclusion criteria

* pregnancy * ongoing pain * respiratory disease * high levels of depression, panic disorder, or other significant mental health problems * not fluent in french

Design outcomes

Primary

MeasureTime frameDescription
Biomakers in dyspnea60 minutesBiomarkers in human model of induced dyspnea

Secondary

MeasureTime frameDescription
Correlation with dyspnea intensity60 minutesCorrelation between intensity of dyspnea and biomarkers
Correlation with dyspnea type60 minutesCorrelation between type of dyspnea and biomarkers

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026